Cat scratch fever medical therapy

Jump to navigation Jump to search

Cat scratch fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Cat scratch fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural history, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cat scratch fever medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cat scratch fever medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cat scratch fever medical therapy

CDC on Cat scratch fever medical therapy

Cat scratch fever medical therapy in the news

Blogs on Cat scratch fever medical therapy

Directions to Hospitals Treating Cat scratch fever

Risk calculators and risk factors for Cat scratch fever medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

The majority of cases of cat scratch disease are self limited. Antimicrobial therapy is administered in select cases and the drug of choice is Azithromycin.

Medical Therapy

Most healthy people will clear the infection without treatment, and antimicrobial therapy is not recommended for immunocompetent patients with mild to moderate Bartonella henselae disease due to the risk of side-effects from antibiotics. Azithromycin, Ciprofloxacin, Doxycycline, and multiple other antibiotics have been used but with unclear benefit.[1]

  • Cat scratch disease[2]
  • Cat scratch disease in patients > 45 kg
  • Preferred regimen: Azithromycin 500 mg PO on day 1 AND 250 mg PO for additional 4 days
  • Cat scratch disease in patients < 45 kg
  • Preferred regimen: Azithromycin 10 mg/kg PO on day 1 AND 5 mg/kg PO for 4 more days

References

  1. Rolain, J.M. (2004). "Recommendations for Treatment of Human Infections Caused by Bartonella Species". Antimicrobial Agents and chemotherapy. 48 (6): 1921–1933. doi:10.1128/AAC.48.6.1921-1933.2004. PMC 415619. PMID 15155180. Unknown parameter |month= ignored (help)
  2. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.

Template:WH Template:WS